EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Novel Scorpion Toxin ω-Buthitoxin-Hf1a Selectively Inhibits Calcium Influx via CaV3.3 and CaV3.2 and Alleviates Allodynia in a Mouse Model of Acute Postsurgical Pain

Dan Wang iD, Volker Herzig iD, Zoltan Dekan, K Johan Rosengren iD, Colton D Payne, Md Mahadhi Hasan, Jiajie Zhuang, Emmanuel Bourinet iD, Lotten Ragnarsson iD, Paul F Alewood iD, Richard J Lewis iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25094745 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Dan Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chinese Medicine and Pharmacy, School of Pharmacy, Jiangsu University, Zhenjiang 212013, China. Hauptthemen laut MEDLINE: Calcium Channels, T-Type, Scorpion Venoms, Hyperalgesia, Disease Models, Animal. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The Natural Science Foundation of the Jiangsu Higher Education Institutions of China, Senior Talent Foundation of Jiangsu University, Innovative and Entrepreneurial Program of Jiangsu Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Venom peptides have evolved to target a wide range of membrane proteins through diverse mechanisms of action and structures, providing promising therapeutic leads for diseases, including pain, epilepsy, and cancer, as well as unique probes of ion channel structure-function. In this work, a high-throughput FLIPR window current screening assay on T-type CaV3.2 guided the isolation of a novel peptide named ω-Buthitoxin-Hf1a from scorpion Hottentotta franzwerneri crude venom. At only 10 amino acid residues with one disulfide bond, it is not only the smallest venom peptide known to target T-type CaVs but also the smallest structured scorpion venom peptide yet discovered. Synthetic Hf1a peptides were prepared with C-terminal amidation (Hf1a-NH2) or a free C-terminus (Hf1a-OH). Electrophysiological characterization revealed Hf1a-NH2 to be a concentration-dependent partial inhibitor of CaV3.2 (IC50 = 1.18 μM) and CaV3.3 (IC50 = 0.49 μM) depolarized currents but was ineffective at CaV3.1. Hf1a-OH did not show activity against any of the three T-type subtypes. Additionally, neither form showed activity against N-type CaV2.2 or L-type calcium channels. The three-dimensional structure of Hf1a-NH2 was determined using NMR spectroscopy and used in docking studies to predict its binding site at CaV3.2 and CaV3.3. As both CaV3.2 and CaV3.3 have been implicated in peripheral pain signaling, the analgesic potential of Hf1a-NH2 was explored in vivo in a mouse model of incision-induced acute post-surgical pain. Consistent with this role, Hf1a-NH2 produced antiallodynia in both mechanical and thermal pain.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Calcium Channels, T-TypeScorpion VenomsHyperalgesiaDisease Models, AnimalPostoperative PainAnimalsMiceCalciumMaleHumansCalcium Channel Blockers

Stichwörter der Autor:innen

T-type calcium channelsacute post-surgical painperipheral painvenom peptides

Substanzen

Calcium Channels, T-TypeScorpion VenomsCalciumCacna1h protein, mouseCalcium Channel BlockersCACNA1H protein, human

Autor:innen und Institutionen

  • Department of Chinese Medicine and Pharmacy, School of Pharmacy, Jiangsu University, Zhenjiang 212013, China.
  • Division of Chemistry and Structural Biology, Institute for Molecular Bioscience, The University of Queensland, Brisbane, QLD 4072, Australia.
  • Centre for Bioinnovation, University of the Sunshine Coast, Sippy Downs, QLD 4556, Australia.
  • School of Science, Technology and Engineering, University of the Sunshine Coast, Sippy Downs, QLD 4556, Australia.
  • School of Biomedical Sciences, The University of Queensland, Brisbane, QLD 4072, Australia.
  • Pharmacy Discipline, Life Science School, Khulna University, Khulna 9208, Bangladesh.

ORCID-Profile: Dan Wang, Volker Herzig, K Johan Rosengren, Emmanuel Bourinet, Lotten Ragnarsson, Paul F Alewood, Richard J Lewis

Förderung

  • The Natural Science Foundation of the Jiangsu Higher Education Institutions of China
  • Senior Talent Foundation of Jiangsu University
  • Innovative and Entrepreneurial Program of Jiangsu Province
  • National Health and Medical Research Council
  • Australian Research Council Future Fellowship
  • NHMRC Program
  • Natural Science Foundation of the Jiangsu Higher Education Institutions of China

Zitieren

APA

Wang, D., Herzig, V., Dekan, Z., Rosengren, K. J., Payne, C. D., Hasan, M. M., Zhuang, J., Bourinet, E., Ragnarsson, L., Alewood, P. F., & Lewis, R. J. (2024). Novel Scorpion Toxin ω-Buthitoxin-Hf1a Selectively Inhibits Calcium Influx via CaV3.3 and CaV3.2 and Alleviates Allodynia in a Mouse Model of Acute Postsurgical Pain. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25094745

Vancouver

Wang D, Herzig V, Dekan Z, Rosengren KJ, Payne CD, Hasan MM, et al. Novel Scorpion Toxin ω-Buthitoxin-Hf1a Selectively Inhibits Calcium Influx via CaV3.3 and CaV3.2 and Alleviates Allodynia in a Mouse Model of Acute Postsurgical Pain. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25094745

BibTeX
@article{Wang2024,
  author = {Wang, Dan and Herzig, Volker and Dekan, Zoltan and Rosengren, K Johan and Payne, Colton D and Hasan, Md Mahadhi and Zhuang, Jiajie and Bourinet, Emmanuel and Ragnarsson, Lotten and Alewood, Paul F and Lewis, Richard J},
  title = {Novel Scorpion Toxin ω-Buthitoxin-Hf1a Selectively Inhibits Calcium Influx via CaV3.3 and CaV3.2 and Alleviates Allodynia in a Mouse Model of Acute Postsurgical Pain},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25094745}
}
Kostenlos starten →